The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Purinergic signaling, involving ATP and related molecules, plays diverse roles in viral infections.
• These roles can either support or impede viral replication and host defense mechanisms.
• Understanding purinergic signaling in viruses provides context for SARS-CoV-2 interactions.

Purpose of the Study:

• To compare and contrast purinergic signaling roles across various viruses with SARS-CoV-2.
• To focus on purinergic receptor activation in antiviral and inflammatory responses during infection.
• To explore potential therapeutic interventions targeting purinergic signaling for COVID-19.

Main Methods:

• Comparative analysis of purinergic signaling in different viral infections.
• Review of current knowledge on purinergic signaling in SARS-CoV-2.
• Discussion of inflammatory and antiviral pathways mediated by purinergic receptors.

Main Results:

• Purinergic signaling is integral to viral infection dynamics and host immune responses.
• Aberrant inflammatory activation via purinergic signaling is a key concern in severe COVID-19, leading to lung edema and respiratory failure.
• Specific purinergic receptor pathways are implicated in the pathogenesis of COVID-19.

Conclusions:

• Modulating purinergic signaling presents a promising therapeutic strategy for mitigating severe COVID-19.
• Interventions targeting purinergic pathways could reduce inflammation and improve patient outcomes.
• Further research into purinergic signaling mechanisms is crucial for developing effective COVID-19 treatments.